Janux Therapeutics • JANX
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.
Ratings
1 / 5
1 rating in the last 12 months
5
4
3
2
1
CEO
Dr. David Campbell, PhD$2.4B
Market Cap • 25/04/20242017
(há 7 anos)
2021
(3 years ago)
NASDAQ
Listagem
San Diego
Sede • California60
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
JANXSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.